Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ED50 of oliceridine for suppression of tracheal intubation response under propofol anesthesia
ChiCTR2400082467Phase 4Not yet recruiting
- Sponsor
- Fuling Central Hospital
- Start
- Mar 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of oliceridine in procedural pain and None, sponsored by Fuling Central Hospital. Primary endpoint: Reaction during tracheal intubation. Planned start Mar 2024; status: not yet recruiting.
02
Drugs
oliceridine
03
Conditions
procedural pain
Beyond the preview
Go deeper on ChiCTR2400082467.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400082467.